<code id='589DB91778'></code><style id='589DB91778'></style>
    • <acronym id='589DB91778'></acronym>
      <center id='589DB91778'><center id='589DB91778'><tfoot id='589DB91778'></tfoot></center><abbr id='589DB91778'><dir id='589DB91778'><tfoot id='589DB91778'></tfoot><noframes id='589DB91778'>

    • <optgroup id='589DB91778'><strike id='589DB91778'><sup id='589DB91778'></sup></strike><code id='589DB91778'></code></optgroup>
        1. <b id='589DB91778'><label id='589DB91778'><select id='589DB91778'><dt id='589DB91778'><span id='589DB91778'></span></dt></select></label></b><u id='589DB91778'></u>
          <i id='589DB91778'><strike id='589DB91778'><tt id='589DB91778'><pre id='589DB91778'></pre></tt></strike></i>

          Home / knowledge / leisure time

          leisure time


          leisure time

          author:comprehensive    Page View:9
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In